Groundbreaking new medical journal to offer insight into patient-centered medicine
PHOENIX, AZ, May 22, 2007-Wolters Kluwer Health, a global provider of drug and medical information services and content to the healthcare and pharmaceutical industries, today announced plans to launch The Patient-Patient Centered Outcomes Research, a groundbreaking, peer-reviwed medical journal that puts the spotlight on patient-centered medicine. This is the first international medical journal dedicated to using the scientific method for accessing patient perspective of therapy and medical technology. The premier issue is due later this year and will initially be published on a quarterly basis.
Also announced today at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting, John F.P. Bridges, PhD, of the Johns Hopkins Bloomberg School of Public Health and an international authority on health outcomes research, was named founding editor. A leading proponent of patient-centered approaches to medicine, Dr. Bridges won the ISPOR Bernie O’Brien New Investigator Award last year for his unique perspective on the field.
“At the most fundamental level, our goal is to empower the patient,” said John F.P. Bridges, Ph. D., Editor, The Patient. “In the past, we simply looked at ways to make the patient well. Today, there’s a shift to a more holistic approach that looks at the process of treating the patient rather than solely at the outcome. In the end, we’re going to help make medicine better for the patient.”
Interest in patient-centered approaches is growing at a rapid pace, as is the body of scientific research on the topic. According to a recent study by Dr. Bridges, there has been exponential growth in the number of studies focusing on patient preferences in medicine over the last decade. For example, the number of conjoint analyses published in medical journals has grown from one every couple of years a decade ago, to over 20 per year today. The Patient was created to address an unmet area of outcomes research by providing a specialized forum and outlet to help the field flourish.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.